OmniAb Presents New Scientific Data on its OmnidAb™ Platform at the 2023 Antibody Engineering & Ther
Introduces the functionality and benefits of the first and only transgenic chicken producing single-domain antibodies to antibody industry thought leaders and research scientists from around the worldEMERYVILLE, Calif.--(BUSINESS WIRE)--OmniAb, Inc. (Nasdaq: OABI) announces the presentation of new scientific data on...